Saumya Ramanathan – Biography
Saumya Ramanathan Ph.D
Dr. Ramanathan obtained her Ph.D. at the University of Arizona, in the lab of Dr. William R. Montfort, where she studied the interplay between nitric oxide signaling and angiogenesis as they pertain to cancer maintenance. For her post-doctoral studies, Dr. Ramanathan went to Dr. Patrick Ryan Potts' lab at UT Southwestern Medical Center in Dallas. There she studied the biochemical functions of MAGEs, a group of proteins that are restricted to expression in the germ line but aberrantly expressed in many cancers.
At Fisk University, Dr. Ramanathan is pursuing her passion for teaching and mentoring. Her lab works on cancer-testis antigens and the role they play in the initiation or sustenance of cancer cell phenotypes. In addition, Dr. Ramanathan's lab studies epigenetics and the role of chromatin modifiers in cancer. She is also a mentor in the Fisk-Vanderbilt Bridge to Ph.D. Program.
For more details on her research group and publications, please visit the lab website at:
PhD – University of Arizona
MS – University of Madras, India
BS – University of Madras, India
- Pineda CT*, Ramanathan S*, Fon Tacer K, Weon JL, Potts, MB, Ou YH, White MA, Potts PR. Degradation of AMPK by a cancer-specific ubiquitin ligase. Cell (2015) Feb 12; 160 (4): 715-28 (* Co-first authors)
- Hao YH, Doyle JM, Ramanathan S, Gomez TS, Jia D, Xu M, Chen ZJ, Billadeau DD, Rosen MK, Potts PR. Regulation of WASH-dependent actin polymerization and protein trafficking by ubiquitination. Cell (2013) Feb 28; 152(5): 1051-64.
- Ramanathan S, Mazzalupo S, Boitano S, Montfort WR. Thrombospondin-1 and Angiotensin II inhibit soluble guanylyl cyclase through an increase in intracellular calcium concentration. Biochemistry (2011) Sep 13; 50(36): 7787-99.